CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF...Licence and Development Agreement • October 4th, 2018 • Orchard Rx LTD • Biological products, (no disgnostic substances) • England
Contract Type FiledOctober 4th, 2018 Company Industry Jurisdiction
SOFTWARE LICENCE AND DEVELOPMENT AGREEMENTLicence and Development Agreement • September 20th, 2006 • Dynasty Gaming Inc • Services-business services, nec • England and Wales
Contract Type FiledSeptember 20th, 2006 Company Industry Jurisdiction
XENOVA LIMITED ANDLicence and Development Agreement • May 27th, 2005 • Xenova Group PLC • Biological products, (no disgnostic substances)
Contract Type FiledMay 27th, 2005 Company Industry
FIFTH AMENDMENT OF THE LICENCE AND DEVELOPMENT AGREEMENT BETWEENLicence and Development Agreement • May 7th, 2020 • Orchard Therapeutics PLC • Biological products, (no disgnostic substances) • England
Contract Type FiledMay 7th, 2020 Company Industry JurisdictionThis fifth amendment of the licence and development agreement (the "Fifth Amendment") is made this 3rd day of May 2019 (the "Fifth Amendment Effective Date")